Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers
Clinical trial NCT03037645 · TERMINATED
Trial details
- NCT number
- NCT03037645
- Sponsor
- Sunesis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-28
- Primary completion
- 2020-08-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.